Navigation Links
Experimental vaccine given during pregnancy reduces stillbirths from common virus

tal amount of virus found in the mothers?blood. The vaccine in the study was developed in collaboration with researchers at AlphaVax, Inc.

Background

CMV is a common viral infection related to the herpes virus and often causes few or no symptoms, according to the National Institute on Deafness and Other Communication Disorders. Every year, 0.5 to 2.5 percent of babies born in the United States are infected with CMV. The virus is transmitted to the fetus through the mother’s placenta.

Dr. Schleiss said that 10 percent to 15 percent of babies with congenital CMV have a long-term disability such as mental retardation, cerebral palsy, and hearing loss. The infection could potentially cause other developmental disabilities such as autism or attention deficit disorder. The virus can also damage the placenta, leading to pregnancy loss.

CMV is present in bodily secretions and is spread through close personal contact, such as kissing or sharing eating utensils. For example, an infant in daycare could give the virus to her pregnant mother by kissing her on the lips, said Dr. Schleiss. The virus can enter through mucosal surfaces such as the mouth or breaks in the skin. It can also be transmitted through nasal secretions, blood transfusions, and sexual contact. Most adults will become infected with CMV at some point during their lives. Dr. Schleiss added that pregnant women may not even know they have the infection.

CMV Vaccine Prototype

The experimental vaccine differs from traditional vaccines, which are made from a whole killed virus. Called a vector vaccine, the experimental vaccine uses an altered virus to deliver one gene from the viral DNA to the animal’s cells. The cells then begin manufacturing the viral protein. Cells of the guinea pigs?immune system detect the viral protein and launch an attack against it. In so doing, they learn to recognize CMV. The gene used in the experime
'"/>

Source:NIH/National Institute of Child Health and Human Development


Page: 1 2 3

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. Experimental shingles vaccine proves effective in nationwide study
3. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
4. Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
5. Experimental drug reverses key cognitive deficits, pathology in Alzheimers
6. Experimental RNA-based drug kills prostate cancer cells effectively and safely
7. Experimental vaccine protects lab animals against several strains of H5N1
8. Experimental vaccine protects mice against deadly 1918 flu virus
9. Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy
10. Research advances quest for HIV-1 vaccine
11. A much-needed shot in the arm for HIV vaccine development
Post Your Comments:
(Date:12/16/2009)... more than 4 billion years before humans showed up, ... more. That suggests they may have something to teach ... expert Prof. Eshel Ben-Jacob of the Raymond and Beverly ... study of bacteria, presents compelling evidence to suggest there ... automatically opt for the swine flu H1N1 shot. , ...
(Date:12/16/2009)... Dec. 1 GestureTek Inc. today ... 3.0 - a turnkey, portable, plug and ... exhibits, entertainment and touring promotions. GestureTek is ... patents in camera-enabled gesture recognition technology for ... Guaranteed for quality, the CUBE has TUV, ...
(Date:12/16/2009)... Inc. is pleased to announce it has acquired ... operating as IgeaCare Systems Inc. The newly formed ... leadership and funding. ,, IgeaCare Solutions Inc. has ... Chief Executive Officer. Under his direction, the new ... and support model; fast and accurate delivery times; ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Scientists discover new genetic immune disorder in children 8716 1Scientists discover new genetic immune disorder in children 8716 2Scientists discover new genetic immune disorder in children 8716 3BioConference Live Call for Abstracts 47912 1BioConference Live Call for Abstracts 47912 2BioConference Live Call for Abstracts 47912 3BioConference Live Call for Abstracts 47912 4Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 1Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 2Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 3Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 4Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 5Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 6Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 7
... of Delaware have uncovered a hidden weapon that one ... States uses to silently and efficiently bump off its ... common reed, believed to have originated in Eurasia, exudes ... substance literally disintegrates the structural protein in the roots ...
... analysis of a tiny green alga has uncovered hundreds ... capture and generation of biomass. Among the 15,000-plus genes ... structure and function of the specialized organelle that houses ... converting light to chemical energy. The genome also ...
... for researching and developing new biopharmaceuticals would be ... of dollars annually, according to a new economic ... and Technology (NIST). , Prepared by RTI ... over the last two decades emphasis in new ...
Other Biology News:UD plant biologists uncover top wetland plant's hidden weapon 2UD plant biologists uncover top wetland plant's hidden weapon 3Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3Biopharmaceutical infrastructure key to lower drug development costs 2
(Date:12/16/2009)... University (NTU) signed the Memorandum of Understanding in ... (CNRS) and the Thales Group of Companies to ... parties are meeting again in Singapore to inaugurate ... , Located at the Research Techno Plaza, ... in science and technology to develop innovations in ...
(Date:12/16/2009)... LAS VEGAS, Dec. 16 Cord Blood ... cord blood stem cell preservation company ( http://www.cordblood-america.com ... potential of stem cells, a biological insurance policy, ... it has reduced its debt by a total ... quarter of 2009 and total debt eliminated for ...
(Date:12/16/2009)... Protocol Assessment with the Food and Drug ... - AEterna Zentaris Inc. (NASDAQ: AEZS ... biopharmaceutical company focused on oncology and endocrine ... partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), ... for perifosine (KRX-0401), the Company,s PI3K/Akt pathway ...
(Date:12/15/2009)... MARINO, Calif., Dec. 15 Epeius Biotechnologies ... targeted genetic medicine, gained international validation of the ... Rexin-G , when scientists around the world rediscovered ... a major locus of cancer pathogenesis and disease ... therapies. Recently, scientists at the NIH National Cancer ...
Breaking Biology Technology:New Singapore-French nanotech lab opens at NTU 2New Singapore-French nanotech lab opens at NTU 3Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... drug screening , , Quinn Lu ... Stratagene has successfully expressed and purified recombinant, wild-type,human ... (MEK1 CA ),using the ESP yeast ... yeast, are full length and undegraded, whereas MEKs,produced ...
... two convenient formats , Michael Borns ... Holly Hogrefe ,Stratagene , Stratagenes prostar ... amplification of RNA in two,convenient formats. The ProSTAR ... DNA polymerase * for amplifying,cDNAs with ...
... ,,,,, PfuTurbo DNA ... Pfx DNA polymerase , Michael ... recently evaluated the properties of Platinum ,Pfx DNA ... polymerase and polymerase-specific antibodies. Comparisons,revealed that Stratagenes PfuTurbo ...
Other Biology Technology:Production of Full-Length, Biologically Active MEK1WT and MEK1CA 2Production of Full-Length, Biologically Active MEK1WT and MEK1CA 3Production of Full-Length, Biologically Active MEK1WT and MEK1CA 4Production of Full-Length, Biologically Active MEK1WT and MEK1CA 5prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification 2prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification 3prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification 4prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification 5prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification 6prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification 7prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification 8prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification 9Comparing Fidelity and Performance of Proofreading PCR Enzymes 2Comparing Fidelity and Performance of Proofreading PCR Enzymes 3Comparing Fidelity and Performance of Proofreading PCR Enzymes 4Comparing Fidelity and Performance of Proofreading PCR Enzymes 5Comparing Fidelity and Performance of Proofreading PCR Enzymes 6Comparing Fidelity and Performance of Proofreading PCR Enzymes 7Comparing Fidelity and Performance of Proofreading PCR Enzymes 8
100 adhesive strips....
Homo sapiens palladin...
Mouse P-Selectin/CD62P MAb (Clone 127933)...
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Biology Products: